483
SURGENEX LLCSURGENEX LLC – FDA 483, Mar 29, 2023
Record Details
An FDA inspection of SURGENEX LLC in Scottsdale, AZ, from March 22-29, 2023, revealed a significant issue with quality control. The firm failed to adequately control in-process Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) and did not ensure sterilization validation requirements were met before product release. This included a failure to process dose audit samples and a delay in opening a deviation report.
View Company Profile
ID · ef3ad5e9-43d0-4898-9884-ea211280ab1c
Other documents for SURGENEX LLC
- 483 - 2021-04-16
- WARNING_LETTER - 2021-04-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.